Related Experiment Videos
New developments in experimental models of inflammatory bowel disease
Charles O Elson1, Yingzi Cong, Robin Lorenz
1Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0007, USA. coelson@uab.edu
Current Opinion in Gastroenterology
|February 11, 2005
Summary
New research on experimental models offers insights into inflammatory bowel diseases (IBD). Understanding microbial-host interactions and immune responses is paving the way for novel IBD therapeutics.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- Inflammatory bowel diseases (IBD) encompass Crohn's disease and ulcerative colitis.
- Current understanding of IBD pathogenesis is evolving.
- Experimental models are crucial for dissecting complex disease mechanisms.
Purpose of the Study:
- To review recent advancements in experimental models of IBD.
- To highlight emerging data on disease pathogenesis and healing.
- To identify new therapeutic avenues based on current research.
Main Methods:
- Review of current literature on experimental IBD models.
- Analysis of data concerning microbial-host interactions.
- Examination of the role of specific immune molecules and cells.
Main Results:
- Advances in understanding microbial-host interactions in the gut.
- Insights into the roles of cytokines (e.g., IL-23) and chemokines (e.g., IP-10).
- Identification of regulatory cells and mechanisms controlling gut inflammation.
- New data on intestinal healing processes post-inflammation.
Conclusions:
- Current data provide fundamental insights into IBD pathogenesis.
- These findings form the basis for developing novel therapeutic strategies.
- Many new treatments are expected to reach clinical application soon.